Data as of Jan 29
| +0.145 / +1.74%|
The 1 analysts offering 12-month price forecasts for Assembly Biosciences Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a -23.30% decrease from the last price of 8.48.
The current consensus among 2 polled investment analysts is to Hold stock in Assembly Biosciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.